SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-08-051385
Filing Date
2008-09-05
Accepted
2008-09-05 12:18:01
Documents
3
Period of Report
2008-08-29
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v125675_8k.htm 8-K 27560
2 v125675_ex3-1.htm EX-3.1 14716
3 v125675_ex99-1.htm EX-99.1 12728
  Complete submission text file 0001144204-08-051385.txt   57038
Mailing Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI F4 710075
Business Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI F4 710075 5619889880
Genesis Pharmaceuticals Enterprises, Inc. (Filer) CIK: 0001091164 (see all company filings)

IRS No.: 651130026 | State of Incorp.: FL | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-53037 | Film No.: 081058038
SIC: 2834 Pharmaceutical Preparations